News

Raw milk is risky, but airborne transmission of H5N1 from cow’s milk is inefficient in mammals

Will Cushman
By Will Cushman
Aug. 31, 2024

While H5N1 avian influenza virus taken from infected cow’s milk makes mice and ferrets sick when dripped into their noses, airborne transmission of the virus between ferrets — a common model for human transmission — appears to be limited.

Yoshihiro Kawaoka

These and other new findings about the strain of H5N1 circulating among North American dairy cattle this year come from a set of laboratory experiments led by University of Wisconsin–Madison researchers, reported today in the journal Nature. Together, they suggest that exposure to raw milk infected with the currently circulating virus poses a real risk of infecting humans, but that the virus may not spread very far or quickly to others.

“This relatively low risk is good news, since it means the virus is unlikely to easily infect others who aren’t exposed to raw infected milk,” says Yoshihiro Kawaoka, a UW–Madison professor of pathobiological sciences who led the study alongside Keith Poulsen, director of the Wisconsin Veterinary Diagnostic Laboratory, and with collaborators at Texas A&M University, Japan’s University of Shizuoka and elsewhere.

Kawaoka cautioned, however, that the findings represent the behavior of the virus in mice and ferrets and may not account for the infection and evolution process in humans.

In their experiments, the UW–Madison team found that mice can become ill with influenza after drinking even relatively small quantities of raw milk taken from an infected cow in New Mexico.

Kawaoka and his colleagues also tested the bovine H5N1 virus’s ability to spread through the air by placing ferrets infected with the virus near but out of physical contact with uninfected ferrets. Ferrets are a common model for understanding how influenza viruses might spread among humans because the small mammals exhibit respiratory symptoms similar to humans who are sick with the flu, including congestion, sneezing and fever. Efficient airborne transmission would signal a serious escalation in the virus’s potential to spark a human pandemic.

Micro image of H5N1 avian flu in epitheilial cells
NIAID/CDC
This colorized transmission electron micrograph shows avian influenza A H5N1 virus particles (green), grown in Madin-Darby canine kidney epithelial cells.

None of the four exposed ferrets became ill, and no virus was recovered from them throughout the course of the study. However upon further testing, the researchers found that one exposed ferret had produced antibodies to the H5N1 virus.

“That suggests that the exposed ferret was infected, indicating some level of airborne transmissibility but not a substantial level,” Kawaoka says.

Separately, the team mixed the bovine H5N1 virus with receptors — molecules the virus binds to in order to enter cells — that are typically recognized by avian or human influenza viruses. They found that bovine H5N1 bound to both types of molecules, representing one more line of evidence of its adaptability to human hosts.

While that adaptability has so far resulted in a limited number of human H5N1 cases, previous influenza viruses that caused human pandemics in 1957 and 1968 did so after developing the ability to bind to receptors bound by human influenza viruses.

Finally, the UW–Madison team found that the virus spread to the mammary glands and muscles of mice infected with H5N1 virus and that the virus spread from mothers to their pups, likely via infected milk. These findings underscore the potential risks of consuming unpasteurized milk and possibly undercooked beef derived from infected cattle if the virus spreads widely among beef cattle, according to Kawaoka.

“The H5N1 virus currently circulating in cattle has limited capacity to transmit in mammals,” he says. “But we need to monitor and contain this virus to prevent its evolution to one that transmits well in humans.”

This article was republished from the University of Wisconsin-Madison News. Read the original here.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Will Cushman
Will Cushman

Will Cushman is a science writer for the University of Wisconsin–Madison Office of Strategic Communication.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Guiding grocery carts to shape healthy habits
Award

Guiding grocery carts to shape healthy habits

Nov. 21, 2024

Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Quantifying how proteins in microbe and host interact
Journal News

Quantifying how proteins in microbe and host interact

Nov. 20, 2024

“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.

Leading the charge for gender equity
Award

Leading the charge for gender equity

Nov. 19, 2024

Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.

CRISPR gene editing: Moving closer to home
News

CRISPR gene editing: Moving closer to home

Nov. 17, 2024

With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.

Finding a missing piece for neurodegenerative disease research
News

Finding a missing piece for neurodegenerative disease research

Nov. 16, 2024

Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.

From the journals: JLR
Journal News

From the journals: JLR

Nov. 15, 2024

Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.